Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - DEPRECIATION & AMORTIZATION
Depreciation & Amortization APLS - Apellis Pharmaceuticals, Inc.
1.7 M
LAST VALUE
6.87%
2 YEAR CAGR
0.00%
5 YEAR CAGR
75.17%
10 YEAR CAGR